China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 14, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	25	1	3	11	29	16
Market Cap Growth	45.88%	-67.93%	-73.95%	-60.15%	83.78%	-89.90%
Enterprise Value	16	-7	2	14	19	9
Last Close Price	2.03	13.44	56.72	1120.00	7360.00	8961.60
PE Ratio	0.10	-	-	-	-	-
PS Ratio	0.31	0.49	1.50	4.37	5.97	3.01
PB Ratio	0.07	0.07	0.20	0.69	1.79	1.65
P/TBV Ratio	1.62	0.07	0.20	0.69	1.79	1.66
P/FCF Ratio	-	-	-	55.27	-	29.44
P/OCF Ratio	-	-	-	42.40	-	16.62
EV/Sales Ratio	8.65	-	0.79	5.37	3.93	1.77
EV/EBITDA Ratio	2.32	-	-	-	-	-
EV/EBIT Ratio	2.38	-	-	-	-	-
EV/FCF Ratio	-	-	-	67.88	-	17.33
Debt / Equity Ratio	0.66	0.27	0.61	0.65	0.76	0.72
Debt / EBITDA Ratio	1.44	-	-	-	-	-
Debt / FCF Ratio	-	-	-	52.20	-	12.75
Asset Turnover	0.08	0.07	0.06	0.08	0.17	0.26
Inventory Turnover	1.31	1.98	1.88	1.10	1.60	2.07
Quick Ratio	1.29	1.51	1.31	1.14	1.00	1.26
Current Ratio	1.40	1.60	1.35	1.31	1.25	1.60
Return on Equity (ROE)	57.63%	-21.65%	-38.15%	-35.42%	-21.67%	-100.33%
Return on Assets (ROA)	18.15%	-4.96%	-10.42%	-9.53%	-4.88%	-4.28%
Return on Capital (ROIC)	24.65%	-6.34%	-12.93%	-11.73%	-6.20%	-5.58%
Return on Capital Employed (ROCE)	43.20%	-	-	-	-	-
Earnings Yield	23.79%	-326.13%	-200.33%	-50.43%	-9.63%	-66.24%
FCF Yield	-11.13%	-203.68%	-5.11%	1.81%	-4.94%	3.40%
Buyback Yield / Dilution	-378.48%	-224.91%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q